🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase 2 trial will investigate the efficacy and safety of trametinib a...
Status
Completed
Location
Universitair Ziekenhuis Brussel
Start Date
2019-01-28
Trial ID
NCT04059224
Treatments Being Tested
This was a retrospective chart review study of all proto-oncogene B-Raf (BR...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2022-10-04
Trial ID
NCT06557291
Perioperative fluid management is used to maintain the perfusion of vital o...
Status
Completed
Location
Ankara Bilkent City Hospital
Start Date
2025-01-01
Trial ID
NCT06967142
Treatments Being Tested
This phase 1/2 trial addresses the efficacy and safety of the combination o...
Status
Unknown
Location
UZ Brussel
Start Date
2018-01-23
Trial ID
NCT03754179
Treatments Being Tested
While the repair of the epidermal barrier in atopic dermatitis is of major ...
Status
Completed
Location
DermResearch, PLLC
Start Date
2010-02
Trial ID
NCT01065714
Treatments Being Tested
The standard treatment for PTCL is CHOP (cyclophosphamide (C), adriamycin (...
Status
Completed
Location
Yale Comprehensive Cancer Center at Yale University School of Medicine
Start Date
2005-11
Trial ID
NCT00337987
The aim of this study is to evaluate the safety and efficacy of lulizumab, ...
Status
Withdrawn
Location
Emory University Hospital
Start Date
2022-01-10
Trial ID
NCT04903054
Treatments Being Tested
Overexpression of inhibitors of apoptosis proteins (IAPs) in patients treat...
Status
Recruiting
Location
CHU de Nîmes
Start Date
2024-09-26
Trial ID
NCT06147960
Treatments Being Tested
This was a retrospective real-world evidence cohort study. The study was co...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2021-07-30
Trial ID
NCT05806268
This study aims specifically to compare the rates of contaminants between s...
Status
Active Not Recruiting
Location
Loyola University medical Center
Start Date
2022-08-01
Trial ID
NCT05554081
Treatments Being Tested